CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 23rd, 2008 • Pharmacopeia Inc • Services-commercial physical & biological research • New York
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 23, 2008 (this “Agreement”), is entered into by and among LIGAND PHARMACEUTICALS INCORPORATED, a Delaware corporation (“Buyer”), PHARMACOPEIA, INC., a Delaware corporation (“Target”), and MELLON INVESTOR SERVICES LLC, a New Jersey limited liability company, as Rights Agent (the “Rights Agent”).
